GNI, Uniservices Joint Research On Melanoma And Breast Cancer

GNI Ltd, a Japan-based global group that develops new drugs, has partnered with Auckland Uniservices Limited in joint research analyzing the genome networks of melanoma and breast cancer.


The research will also delve into the effects of anticancer reagents on the genome network in patients. The genome network has been noted as a new approach in developing new drugs through discovery of druggable genome by analyzing tumor-inducing genomes that lead to the spread of diseases.


The project was commissioned by the Health Research Council of New Zealand (HRC) and Breast Cancer Research Trust (BCRT).


By Chris Lui, JCN Staff Writer


Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.


JCN